Patient Note — 202147

4/23/26, 6:42 AM Print Preview [PATIENT_NAME] DOB: [DOB] (75 yo M) Acc No. [ACCOUNT_ID] DOS: 01/28/2026 Stent Removal Patient: [PATIENT_NAME] Provider: [PATIENT_NAME] Account: [ACCOUNT_ID] DOB: [DOB] Age: 75 Y Sex: Male Date: 01/28/2026 Phone: [PHONE] Address: [ADDRESS] Pcp: [PATIENT_NAME] Structured Data: How did you hear about us? : Other; Patient's temperature : 0 Subjective: Chief Complaints: 1. STENT REMOVAL. HPI: General Urology: 75yM, with hx of kidney stones and S/p R URS/LL, comes for stent removal. 01/28/2025 F/u of BPH and renal calculus. S/p R URS/LL (01/23/2025). 12/2025 CT ap (12/2025): proximal R ureteral stone 0.5 cm with mild hydroneph. 11/19/2025 FU kidney stones, OAB, and BPH. CT scan (11/2025): 5 mm R proximal ureteral stone. 2/6/2025 Previous hx: strong flow, 1-2x nocturia medication: DDAVP Urgency is most bothersome symptom s/p TURP in 2000 hx of Low T Treatment: Androgel (d/c in Nov23) hx of elevated PSA Treatment: Finasteride (d/c in Nov'23) 3/27/24 postop s/p TURBT of baldder tumor located on prostatic urethra 3/22/24 good flow new bothersome urgency, 5-6x nocturia 4/8/24 FU bladder tumor, OAB, BPH, and elevated PSA for path rev notes blood in urine multiple times during the day urgency, good flow Provider: [PATIENT_NAME] Date: 01/28/2026 Generated for Printing/Faxing/eTransmitting on: 04/23/2026 09:42 AM EDT 1/6 4/23/26, 6:42 AM Print Preview [PATIENT_NAME] DOB: [DOB] (75 yo M) Acc No. [ACCOUNT_ID] DOS: 01/28/2026 5/16/24 FU elevated PSA, OAB, and BPH 2-3x nocturia Failed oxybutynin (SE of dry mouth). But he did not notice any benefit. 2/5/25 FU OAB s/p Interstim I&II 1/21/2025 3/10/25 FU elevated PSA and OAB 8/4/2025 OAB, elevated PSA, bladder tumor, enlarged prostate, ED, hypogonadism, elevated BP. Improvement with interstim but still have bothersome occasional urgency episodes. Nocturia 1x per night. ============================================= The patient's past workup includes: s/p TURBT of baldder tumor located on prostatic urethra 3/22/24 Path report (Mar'24): lead placement in correct location Cysto (Mar'24) showed grade 1 tuberculation, bilateral apical tissue regrowth, 1cm area of bladder neck left> right uncertain if papillary lesion vs inflammation. sacral x-ray (Feb'25): neural stimulator overlying in right pelvis electrode overlying right sacrum PSA: 10.64 (Feb'25); 7.02 (Nov'24); 6.41 (May'24); 3.37 (6.74 adjusted for finasteride; Nov'23); 2.21 (4.4 adjusted for finasteride Sep'23) Biopsy in 2005, 2007, 2009, and 2017 (all negative) pMRI (Dec'23): Vol: 57g, PIRADS 3; 13 mm lesion in the left mid gland PIRADS 3; 10 mm lesion in the right midgland PIRADS 3; 8 mm lesion in the right mid gland of the posterior lateral peripheral zone PIRADS 3 pMRI (2021): Normal, 41 g. BPH screening: Urocuff information Date 10/10/2023 Peak flow (mL/s) 21.3 Volume voided (cc) 328 Bladder pressure (cm H2O) 175 PVR (mL) 0 Category high pressure/high flow PFS score (%) 75 Erectile Dysfunction screening: Penile US Date 10/31/202